APTAMIR

Owner

Goods & Services

MicroRNA-targeted pharmaceutical drug research and development in the field of biotech herapeutics; development of RNA-based pharmaceutical drugs and therapeutic compounds; development of drugs for the pharmaceutical and biotech industries for the treatment of a wide variety of diseases and other conditions, namely, cardiovascular diseases, endocrine and metabolic diseases, obesity and weight disorders, hepatic and gastro-intestinal diseases, inflammatory diseases, and malignant diseases; Scientific and technological research services, namely, profiling and analysis of miRNA sequences; developing computer generated models and simulations for others; providing "in vitro" and "in vivo" preclinical and clinical testing of microRNA analogs and aptamers for scientific, research, healthcare, product development, consulting, and educational purposes

Medicinal and biological preparations for research, laboratory use, pharmaceutical, clinical or medical laboratory use, namely, preparations for the modulation of gene and protein expression working at DNA transcription, RNA translation and/or degradation processes related thereto